首页> 外国专利> GENE DIFFERENTIALLY EXPRESSED IN BREAST AND BLADDER CANCER AND ENCODED POLYPEPTIDES

GENE DIFFERENTIALLY EXPRESSED IN BREAST AND BLADDER CANCER AND ENCODED POLYPEPTIDES

机译:基因在乳腺癌和膀胱癌及编码多肽中差异表达

摘要

The present invention relates to a novel human gene that is differentiallyexpressed in human carcinoma. More specifically, the present invention relatesto a polynucleotide encoding a novel human polypeptide named C35 that isoverexpressed in human breast and bladder carcinoma. This invention alsorelates to C35 polypeptide, in particular C35 peptide epitopes and C35 peptideepitope analogs, as well as vectors, host cells, antibodies directed to C35polypeptides, and the recombinant methods for producing the same. The presentinvention further relates to diagnostic methods for detecting carcinomas,including human breast carcinomas. The present invention further relates tothe formulation and use of the C35 gene and polypeptides, in particular C35peptide epitopes and C35 peptide epitope analogs, in immunogenic compositionsor vaccines, to induce antibody or cell-mediated immunity against targetcells, such as tumor cells, that express the C35 gene. The invention furtherrelates to screening methods for identifying agonists and antagonists of C35activity.
机译:本发明涉及新的人类基因,其差异在人类癌症中表达。更具体地,本发明涉及编码一个新的人类多肽称为C35的多核苷酸在人的乳腺癌和膀胱癌中过度表达。本发明也涉及C35多肽,特别是C35肽表位和C35肽表位类似物,以及载体,宿主细胞,针对C35的抗体多肽及其重组方法。现在本发明进一步涉及用于检测癌的诊断方法,包括人类乳腺癌。本发明进一步涉及C35基因和多肽,特别是C35的配方和用途免疫原性组合物中的肽表位和C35肽表位类似物或疫苗,以诱导针对靶标的抗体或细胞介导的免疫力表达C35基因的细胞,例如肿瘤细胞。本发明进一步与鉴定C35激动剂和拮抗剂的筛选方法有关活动。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号